Member Info for inanaco

Ruck i hope you do .,.......

This is the first time any actual "science" discussion has been attempted ..

and with your words ...

"""" OK, if you really want it: """"

yea bring it on ...

Gunthorpe ... no Ruck has pasted a research paper ... but does he understand it ?

well, we will see

yes i have posted that link numerous times ...

and what is the problem ?

so you make a statement Ruck as you are "smart"

""" Are YOU aware of the cancer promoting side-effects of IFN-y?"""

then come out with this

""" I'm not sure it is in my best interests as a shareholder to post stuff like that. People need to do their own research."""

Space Cadet ... case rested

LOL ... you best explain the cancer promoting side effects Ruck ... of interferon Gamma

Scancell SCIB1 trial has come along way since 2016 Knowlesi .. i even question that NXC is Evans .. off the top of his head he could not remember patient numbers

His words

"""" The second lesson would be to understand the quantum of data needed to convince a partner at the stage Scib1 was then at. We had 14 patients from memory and that was driven by the funds available - I think some of the feedback was that if we had 50 to 60 patients then we could have got a deal (possibly).""""

Now in the end of year 2015 while Evens is at the table ...

In total, 35 patients have now been treated with SCIB1, including ten patients at the higher 8mg dose. Six patients remain on long-term treatment and have received between two and ten additional 4mg or 8mg doses of SCIB1 every three to six months.

this is like today when Tony Blair tries to run the country ...

Directorate Change
Thu, 7th Jan 2016 07:00
RNS Number : 0794L
Scancell Holdings Plc
07 January 2016
Â
?

Scancell Holdings Plc

("Scancell" or the "Company")

Directorate Change

Â

Scancell Holdings Plc, (AIM:SCLP), today announces the appointment of John Chiplin as Non-Executive Chairman, succeeding current Chairman David Evans who has offered his resignation to the Board in line with his personal decision to reduce his number of Non-Executive Chairman roles. John Chiplin will take on this position with immediate effect.

Non-Executive Chairman roles

you just fail to see the link between --------- Interferon Gamma and a T cell working

last post was to Ruck

Tommy ... the trials are funded to commence ...

read whatever you like into David Evans posts .. but they are actually old hat .. he was a Non Executive chairman ..

not an executive ... that was then Richard and Lindy as joint CEO ...

so Evens was not involved in the day to day business at all .. and is not involved in the current position so has no idea what is going on apart from RNS

he has already stated he is NOT up to speed with the science

SCIB1 .. has proven itself already ..

you just fail to see the link between --------- Interferon Gamma and a T cell working

I don't have to be careful .. i actually read the data presented .. from all sources

your problem is, you cannot identify a negative but assume one ...

you keep claiming you are smarter than me ... but the evidence of your defence of that statement is very very limited

find a mechanism of failure ... Good luck

just remember every time you experiment on the mouse ............

its a 50 day turnaround ..

just remember every time you experiment on the mouse ............

its a 50 day turnaround ..

Problem is .. Scancell understands Shareholder value ...

shareholders actually look at it differently .. with the short term being the dominate

tried to explain that with the Modi1 vaccine

if you read the history it started off as Vim 1 and Vim 2 ... it would work with that and could have been in trial 3 years ago .. But ...

Lindy understood from the Immunobody trials the importance of the high avidity t cell .. and inflammation

so cancer is in two parts ...

the solid bit .. and the rogue cells that create secondary cancers

Both had to be destroyed which is why they advanced the vaccine further

adding ENO epitope and the Amplivant to boost inflammation

so we now target ... both cancer type the solid and the rogue ..

we induce "Memory" Cells ie give the mouse cancer again and the memory kicks in killing the visible cancer that shows that those rogue cells also have been destroyed

and

we can cause Inflammation on cold cancers

so This "delay" ..... is about long term shareholder value over short term gain yet the market being short term just fails to accept this rational explanation

that is what Scancell is fighting against .... we build Rolls Royce vaccines ... not Trabants

now having built the first vaccine that has produced this awesome mouse data .. Scancell then announces

a new patent having identified another series of epitopes from Homocitrulline which generate an even more aggressive t cell

and the market ignores it ...

not sure what Scancell can do ... the Trials will prove who is right ....

It's all about proving up to levels ... to gain the most from so little ... lets take NXC at his word

SCIB1 needed more data to do a deal 2014 and 50 patients

SCIB! now has 5 year data profile and we are about to add a further 25 patients .... taking us to 50

SCIB2 has a deal

Modi1 ... in trial soon
Modi2 .. defined, soon be in manufacture

TCR ... taking on staff specific for this area is significant

Not sure Scancell can tell you anything else that is of actual value without damaging future patents

Ivy Posts

"""" Trying to help people understand the market does not always move with fundamentals."""

so when i post """ the market has not got it yet""" ... LOL

Ivy you are just unbelievable ..

""""Simply stating I only invest long term in Company’s like here where I am comfortable with the science""""

then contradicts himself

"""Just some pontificate on about the science whilst not recognising or understanding how this market works"""

lets Wait for the

""This is how the market works post"""

prepare to be enlightened

LOL ... The Space Cadets have no chance ..

Deadly ..

I thing this subject was approached the other day, if you start reading something from a negative perspective . you will perceive it as a negative ....

Confirmation bias, also called confirmatory bias or myside bias, is the tendency to search for, interpret, favor, and recall information in a way that confirms one's preexisting beliefs or hypotheses. It is a type of cognitive bias and a systematic error of inductive reasoning.

way to much time spent in the past .... clearly the past is priced in T/F

The market may not appreciate Scancell today ...

Tomorrow .. ? who knows ..

anyway NXC is staying out of the science discussions, and was setting the record straight on history.

Does it make any difference ? Panama is still moaning LOL

like i keep pointing out ......... T cell goes active against the peptide it leaves a trace IFN we know that Immunobody achieves this from the trials

Cancer when subjected to IFN ... displays PD1 .....

synergy ...